Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
CH3(CH2)10COOCH=CH2
CAS Number:
Molecular Weight:
226.36
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
218-414-7
Beilstein/REAXYS Number:
1778369
MDL number:
Assay:
≥99.0% (GC)
InChI key
GLVVKKSPKXTQRB-UHFFFAOYSA-N
InChI
1S/C14H26O2/c1-3-5-6-7-8-9-10-11-12-13-14(15)16-4-2/h4H,2-3,5-13H2,1H3
SMILES string
CCCCCCCCCCCC(=O)OC=C
assay
≥99.0% (GC)
refractive index
n20/D 1.441
bp
254 °C/1013 hPa (lit.)
density
0.871 g/mL at 20 °C (lit.)
functional group
ester
Quality Level
Looking for similar products? Visit Product Comparison Guide
Related Categories
General description
Vinyl laurate acts as an acyl donor during the transeterification of L-α-glycerophosphorylcholine (GPC) in the presence of Candida antarctica lipase B as catalyst to form lysophosphatidylcholine (LPC).
Application
Vinyl laurate can be used to synthesize the following:
- sucrose laurate esters from sucrose in organic solvents
- poly(vinyl laurate) (PVL)latexes
- porous conducting ‘‘soft′′ polymer foams which can be used as gas sensors
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
257.0 °F
flash_point_c
125 °C
ppe
Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
"Conducting Nanocomposite Polymer Foams from Ice-Crystal-Templated Assembly of Mixtures of Colloids"
Colard.L.AC, et al.
Advanced Mat., 21(28), 2894-2898 (2009)
Lysophosphatidylcholine synthesis with Candida antarctica lipase B (Novozym 435)
Virto C and Adlercreutz P
Enzyme and Microbial Technology, 26(08), 630-635 (2000)
Sophie Cohen et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 60(7), 1111-1119 (2014-12-18)
Despite the declining incidence of severe neurological complications such as HIV encephalopathy, human immunodeficiency virus (HIV) infection in children is still associated with a range of cognitive problems. Although most HIV-infected children in industrialized countries are immigrants with a relatively
Janne Estill et al.
PloS one, 10(3), e0119299-e0119299 (2015-03-21)
The cost-effectiveness of routine viral load (VL) monitoring of HIV-infected patients on antiretroviral therapy (ART) depends on various factors that differ between settings and across time. Low-cost point-of-care (POC) tests for VL are in development and may make routine VL
R U Trappe et al.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 15(4), 1091-1100 (2015-03-05)
Tailoring treatment by patient strata based on the risk of disease progression and treatment toxicity might improve outcomes of patients with posttransplant lymphoproliferative disorder (PTLD). We analysed the cohort of 70 patients treated in the international, multicenter phase II PTLD-1
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service